# AYTU (Aytu Biopharma, Inc.) - SEC EDGAR Financial Statements

> Aytu Biopharma, Inc. reported $58.52M in revenue and a net loss of $20.10M for the trailing twelve months ended September 30, 2026 (up 6.9% year over year), with a 63.3% gross margin and a -18.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/AYTU
- Markdown: https://convexityos.com/fundamentals/AYTU.md
- SEC CIK: 0001385818
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001385818&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $58.52M | +6.9% YoY |
| Operating Income | TTM | -$10.74M | -18.4% margin |
| Net Income | TTM | -$20.10M | -34.3% net margin |
| Diluted EPS | TTM | -$1.04 | Split-adjusted |
| Free Cash Flow | TTM | $3.25M | 5.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $25.49M | Total debt: $11.54M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $57.57M | $66.38M | $65.18M | $107.4M | $96.67M | $65.63M | $27.63M | $7.32M | $3.66M | $3.22M |
| Cost of Revenue | $20.75M | $20.55M | $16.13M | $40.77M | $44.39M | $36.43M | $8.28M | $2.20M | $2.05M | $1.42M |
| **Gross Profit** | $36.82M | $45.83M | $49.05M | $66.63M | $52.28M | $29.20M | $19.35M | $5.12M | $1.61M | $1.80M |
| Research & Development | $0 | $1.33M | $2.77M | $4.09M | $12.66M | $5.62M | $1.72M | $589K | $168K | $960K |
| Selling, General & Admin | $42.64M | $38.28M | $42.04M | $70.08M | $69.88M | $55.81M | $34.80M | $18.89M | $17.73M | $17.44M |
| Total Operating Expenses | $45.13M | $53.66M | $50.65M | $83.70M | $162.2M | $88.07M | $40.48M | $24.17M | $23.36M | $23.35M |
| **Operating Income** | -$8.31M | -$7.83M | -$1.59M | -$17.07M | -$109.9M | -$58.87M | -$21.13M | -$16.85M | -$19.70M | -$20.13M |
| **EBITDA** | -$4.38M | -$2.45M | $6.68M | -$8.25M | -$99.76M | -$49.67M | -$15.42M | -$14.12M | -$17.11M | -$15.76M |
| Interest Expense | $1.90M | $3.70M | $5.06M | $4.96M | $900K | -- | $2.61M | $536K | $749K | $2.53M |
| Income Before Tax | -$14.23M | -$13.74M | -$10.38M | -$17.05M | -$108.9M | -$58.03M | -$13.62M | -- | -- | -- |
| Income Tax Expense | $21K | $437K | $2.14M | $0 | -$110K | $259K | $0 | $0 | $0 | $0 |
| **Net Income** | -$14.25M | -$13.56M | -$15.84M | -$17.05M | -$108.8M | -$58.29M | -$13.62M | -$27.13M | -$10.19M | -$22.51M |
| Basic EPS | -$1.16 | -$2.16 | -$2.86 | -$5.11 | -$74.01 | -$69.60 | -$60.20 | -$69.60 | -$306.20 | -$966.00 |
| **Diluted EPS** | -- | -- | -- | -$5.11 | -$74.01 | -$69.60 | -$60.20 | -$69.60 | -$306.20 | -$966.00 |
| Basic Shares Outstanding | 12.3M | 6.3M | 5.5M | 3.3M | 1.5M | 837.3K | 226.0K | 389.7K | 33.3K | 23.3K |
| Diluted Shares Outstanding | -- | -- | -- | 3.3M | 1.5M | 837.3K | 226.0K | 389.7K | 33.3K | 23.3K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $14.84M | $16.11M | $12.41M | $15.16M | $13.89M | $15.13M | $18.45M | $16.22M |
| Cost of Revenue | $5.41M | $5.70M | $4.81M | $5.54M | $4.70M | $4.88M | $5.65M | $5.43M |
| **Gross Profit** | $9.44M | $10.41M | $7.60M | $9.62M | $9.19M | $10.25M | $12.81M | $10.79M |
| Research & Development | -- | $0 | $0 | $0 | $0 | $216K | $162K | $522K |
| Selling, General & Admin | $12.61M | $10.43M | $10.90M | $11.07M | $10.25M | $8.48M | $9.30M | $9.72M |
| Total Operating Expenses | $13.37M | $11.19M | $11.66M | $11.59M | $10.69M | $17.88M | $10.38M | $12.48M |
| **Operating Income** | -$3.93M | -$777K | -$4.06M | -$1.97M | -$1.50M | -$7.62M | $2.42M | -$1.70M |
| **EBITDA** | -$2.81M | $344K | -$2.94M | -$1.08M | -$701K | -$6.16M | $3.71M | -$403K |
| Interest Expense | $408K | $383K | $436K | $560K | $516K | $730K | $900K | $1.08M |
| Income Before Tax | -$3.88M | -$4.0K | -$5.61M | -$10.58M | $1.97M | -$19.44M | $3.82M | $382K |
| Income Tax Expense | $0 | $11K | $10K | $0 | $0 | $437K | -$122K | -$283K |
| **Net Income** | -$3.88M | -$15K | -$5.62M | -$10.58M | $1.97M | -$19.82M | $3.99M | $788K |
| Basic EPS | -$0.20 | -- | -$0.53 | -$1.05 | $0.21 | -- | $0.65 | $0.13 |
| **Diluted EPS** | -$0.20 | -- | -$0.53 | -$1.05 | -$0.08 | -- | $0.21 | -$0.26 |
| Basic Shares Outstanding | 19.3M | -- | 10.5M | 10.0M | 9.4M | -- | 6.1M | 6.1M |
| Diluted Shares Outstanding | 19.3M | -- | 10.5M | 10.0M | 19.5M | -- | 8.2M | 8.5M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $26.31M | $30.95M | $20.01M | $22.98M | $19.36M | $49.65M | $48.08M | $11.04M | $7.01M | $802K |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Cash & Short-Term Investments** | $26.31M | $30.95M | $20.01M | $22.98M | $19.36M | $49.65M | $48.08M | $11.04M | $7.01M | $878K |
| Accounts Receivable, Net | $22.78M | $31.16M | $23.53M | $28.94M | $21.71M | $28.18M | $5.63M | $1.74M | $579K | $528K |
| Inventory | $6.86M | $11.43M | $12.14M | $11.99M | $10.85M | $16.34M | $10.00M | $1.44M | $1.34M | $1.31M |
| Other Current Assets | -- | -- | $61.89M | $71.08M | $633K | $1.04M | $5.74M | $0 | -- | -- |
| **Total Current Assets** | $61.76M | $79.18M | $61.89M | $72.83M | $59.93M | $105.2M | $75.42M | $15.43M | $9.47M | $3.03M |
| Property, Plant & Equipment, Net | $385K | $532K | $693K | $1.81M | $3.02M | $5.14M | $259K | $204K | $219K | $647K |
| Goodwill | -- | -- | -- | $0 | $0 | $65.80M | $28.09M | $0 | -- | $238K |
| Intangible Assets | $41.40M | $42.20M | $52.45M | $58.97M | $70.63M | $85.46M | $48.85M | $48.85M | $246K | $271K |
| Other Non-Current Assets | $601K | $1.20M | $2.19M | $2.54M | $766K | $465K | $33K | $18.86M | $11.12M | $9.23M |
| **Total Non-Current Assets** | $43.25M | $45.00M | $56.20M | $65.38M | $77.69M | $160.4M | $77.87M | $19.29M | $11.59M | $11.97M |
| **Total Assets** | $105.0M | $124.2M | $118.1M | $136.5M | $137.6M | $265.7M | $153.3M | $34.72M | $21.06M | $15.00M |
| Accounts Payable | $11.28M | $10.60M | $10.31M | $13.48M | -- | $19.25M | $11.64M | $2.13M | $2.12M | $2.22M |
| Short-Term Debt | $1.86M | $1.86M | $4.25M | $1.65M | $3.81M | -- | $982K | $0 | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | $400K | $200K | $339K | $0 | $0 | -- |
| Other Current Liabilities | $239K | $3.38M | $8.96M | $7.09M | $5.36M | $8.35M | $840K | $0 | -- | -- |
| **Total Current Liabilities** | $54.66M | $63.06M | $62.23M | $69.02M | $64.44M | $109.4M | $28.76M | $5.37M | $3.39M | $3.61M |
| Long-Term Debt | $9.10M | $10.89M | $10.88M | $14.71M | $14.28M | $180K | $0 | -- | $0 | -- |
| Other Non-Current Liabilities | $4.77M | $4.92M | $4.53M | $6.97M | $12.80M | $18.48M | $11K | $0 | -- | -- |
| **Total Non-Current Liabilities** | $15.07M | $42.15M | $28.15M | $28.09M | $28.87M | $18.66M | $29.52M | $22.26M | $4.24M | $7.39M |
| **Total Liabilities** | $69.73M | $105.2M | $90.38M | $97.11M | $93.31M | $128.1M | $58.28M | $27.63M | $7.64M | $11.00M |
| **Total Debt (incl. Leases)** | $12.03M | $13.87M | $14.02M | $16.89M | $17.69M | $3.74M | $2.01M | $0 | $0 | -- |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $4.0K | $3.0K | $1.0K | $1.8K | $179 | $4 |
| Retained Earnings | -$347.8M | -$333.5M | -$320.0M | -$304.1M | -$287.1M | -$178.3M | -$120.0M | -$106.4M | -$79.26M | -$69.07M |
| **Total Stockholders' Equity** | $35.27M | $18.97M | $27.72M | $39.36M | $44.31M | $137.6M | $95.02M | $7.09M | $13.42M | $4.00M |
| Total Equity | $35.27M | $18.97M | $27.72M | $39.36M | $44.31M | $137.6M | $95.02M | $7.09M | $13.42M | $4.00M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $25.49M | $26.31M | $26.71M | $30.02M | $32.63M | $30.95M | $18.17M | $20.40M |
| **Cash & Short-Term Investments** | $25.49M | $26.31M | $26.71M | $30.02M | $32.63M | $30.95M | $18.17M | $20.40M |
| Accounts Receivable, Net | $20.33M | $22.78M | $24.49M | $30.92M | $33.23M | $31.16M | $35.83M | $25.40M |
| Inventory | $6.02M | $6.86M | $7.46M | $8.66M | $10.10M | $11.43M | $11.06M | $11.09M |
| Other Current Assets | -- | -- | -- | -- | -- | -- | -- | $63.05M |
| **Total Current Assets** | $57.16M | $61.76M | $67.33M | $76.24M | $81.11M | $79.18M | $72.51M | -- |
| Property, Plant & Equipment, Net | $353K | $385K | $407K | $484K | $500K | $532K | $546K | $516K |
| Intangible Assets | $40.32M | $41.40M | $42.49M | $43.58M | $41.43M | $42.20M | $48.71M | $49.96M |
| Other Non-Current Assets | $535K | $601K | $556K | $738K | $939K | $1.20M | $1.32M | $1.52M |
| **Total Non-Current Assets** | $42.01M | $43.25M | $44.36M | $45.76M | $43.88M | $45.00M | $51.69M | $53.17M |
| **Total Assets** | $99.17M | $105.0M | $111.7M | $122.0M | $125.0M | $124.2M | $124.2M | $116.2M |
| Accounts Payable | $11.51M | $11.28M | $13.21M | $14.26M | $12.34M | $10.60M | $12.04M | $11.70M |
| Short-Term Debt | $1.86M | $1.86M | $1.86M | $1.86M | $1.86M | $1.86M | $1.86M | $5.87M |
| Other Current Liabilities | $258K | $239K | $220K | $216K | $221K | $3.38M | $5.05M | $7.11M |
| **Total Current Liabilities** | $53.33M | $54.66M | $59.97M | $65.56M | $65.99M | $63.06M | $70.71M | $64.05M |
| Long-Term Debt | $8.65M | $9.10M | $9.55M | $10.00M | $10.45M | $10.89M | $9.54M | $9.98M |
| Other Non-Current Liabilities | $4.70M | $4.77M | $4.84M | $4.90M | $4.95M | $4.92M | $4.94M | $5.04M |
| **Total Non-Current Liabilities** | $14.28M | $15.07M | $16.57M | $42.24M | $35.82M | $42.15M | $18.60M | $21.41M |
| **Total Liabilities** | $67.61M | $69.73M | $76.55M | $107.8M | $101.8M | $105.2M | $89.30M | $85.46M |
| **Total Debt (incl. Leases)** | $11.54M | $12.03M | $12.53M | $13.03M | $13.53M | $13.87M | $12.49M | $13.13M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$351.7M | -$347.8M | -$347.8M | -$342.2M | -$331.6M | -$333.5M | -$313.7M | -$317.7M |
| **Total Stockholders' Equity** | $31.56M | $35.27M | $35.14M | $14.20M | $23.17M | $18.97M | $34.90M | $30.77M |
| Total Equity | $31.56M | $35.27M | $35.14M | $14.20M | $23.17M | $18.97M | $34.90M | $30.77M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.25M | -$13.56M | -$15.84M | -$17.05M | -$108.8M | -$58.29M | -$13.62M | -$27.13M | -$10.19M | -$22.51M |
| Depreciation & Amortization | $3.93M | $5.38M | $8.27M | $8.81M | $10.15M | $9.20M | $5.71M | $2.73M | $2.59M | $4.36M |
| Stock-Based Compensation | $691K | $576K | $2.37M | $6.05M | $5.25M | $3.57M | $1.08M | $1.02M | $597K | $2.50M |
| Change in Receivables | $8.38M | -$7.63M | $5.20M | -$7.15M | $6.53M | $1.54M | -$3.56M | -$1.16M | -$51K | -$355K |
| Change in Inventory | $2.39M | $382K | -$4.82M | -$3.61M | $1.30M | $2.79M | -$8.22M | -$101K | -$27K | $195K |
| Change in Payables | -$2.32M | $287K | -$2.08M | $2.38M | -$7.68M | -$3.25M | -$1.38M | -- | -- | -- |
| **Operating Cash Flow** | $3.28M | -$1.94M | -$1.39M | -$5.13M | -$28.82M | -$25.96M | -$28.37M | -$13.83M | -$15.94M | -$13.83M |
| Capital Expenditure | -$29K | -$228K | -$329K | -- | $0 | -$2.34M | $0 | -$60K | -$75K | -$112K |
| **Free Cash Flow** | $3.25M | -$2.17M | -$1.72M | -- | -$28.82M | -$28.30M | -$28.37M | -$13.89M | -$16.02M | -$13.94M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$92K |
| **Investing Cash Flow** | -$29K | -$2.56M | -$329K | -$117K | -$3.25M | -$2.78M | -$5.66M | -$1.06M | -$484K | -$3.53M |
| Common Stock Issued | -- | -- | -- | $15.57M | $11.69M | $45.05M | $65.73M | $15.18M | $11.84M | $740K |
| **Financing Cash Flow** | -$7.90M | $15.44M | -$1.26M | $8.87M | $1.53M | $30.31M | $71.07M | $19.08M | $22.66M | $10.19M |
| **Net Change in Cash** | -$4.64M | $10.95M | -$2.98M | $3.62M | -$30.54M | $1.57M | $37.04M | $4.18M | $6.23M | -$7.18M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.88M | -$15K | -$5.62M | -$10.58M | $1.97M | -$19.82M | $3.99M | $788K |
| Depreciation & Amortization | $1.12M | $1.12M | $1.12M | $885K | $803K | $1.46M | $1.29M | $1.29M |
| Stock-Based Compensation | $171K | $146K | $148K | $283K | $114K | $113K | $139K | $151K |
| Change in Receivables | $2.45M | $1.71M | $6.43M | $2.30M | -$2.07M | $4.67M | -$10.51M | -$2.27M |
| Change in Inventory | $476K | $179K | $543K | $609K | $1.06M | -$518K | -$61K | $627K |
| Change in Payables | $223K | -$1.93M | -$1.04M | -$1.08M | $1.74M | -$1.44M | $398K | -$1.81M |
| **Operating Cash Flow** | -$275K | $4.41M | -$4.18M | $3.67M | -$618K | $2.80M | -$6.46M | $2.90M |
| Capital Expenditure | -- | -$12K | $0 | -$17K | $0 | -$17K | -$69K | -$6.0K |
| **Free Cash Flow** | -- | $4.39M | -$4.18M | $3.66M | -$618K | $2.79M | -$6.52M | $2.90M |
| **Investing Cash Flow** | -- | -$12K | $0 | -$17K | $0 | -$3.02M | -$69K | $145K |
| **Financing Cash Flow** | -$539K | -$4.80M | $872K | -$6.26M | $2.30M | $12.99M | $4.30M | -$2.76M |
| **Net Change in Cash** | -$814K | -$407K | -$3.31M | -$2.60M | $1.68M | $12.78M | -$2.23M | $290K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 64.0% | 69.0% | 75.3% | 62.0% | 54.1% | 44.5% | 70.0% | 69.9% | 44.0% | 56.0% |
| **Operating Margin** | -14.4% | -11.8% | -2.4% | -15.9% | -113.7% | -89.7% | -76.5% | -230.1% | -538.2% | -624.7% |
| **Net Profit Margin** | -24.8% | -20.4% | -24.3% | -15.9% | -112.5% | -88.8% | -49.3% | -370.6% | -278.3% | -698.7% |
| Return on Equity (ROE) | -40.4% | -71.5% | -57.2% | -43.3% | -245.5% | -42.4% | -14.3% | -382.8% | -75.9% | -562.7% |
| Return on Assets (ROA) | -13.6% | -10.9% | -13.4% | -12.5% | -79.0% | -21.9% | -8.9% | -78.1% | -48.4% | -150.1% |
| Current Ratio | 1.13x | 1.26x | 0.99x | 1.06x | 0.93x | 0.96x | 2.62x | 2.87x | 2.79x | 0.84x |
| Quick Ratio | 1.00x | 1.07x | 0.80x | 0.88x | 0.76x | 0.81x | 2.27x | 2.60x | 2.40x | 0.48x |
| Debt to Equity | 0.34x | 0.73x | 0.51x | 0.43x | 0.40x | 0.03x | 0.02x | 0.00x | 0.00x | -- |
| **Revenue Growth (YoY)** | -13.3% | +1.8% | -39.3% | +11.1% | +47.3% | +137.5% | +277.5% | +100.0% | +13.6% | +25.7% |
| Gross Profit Growth (YoY) | -19.7% | -6.6% | -26.4% | +27.4% | +79.1% | +50.9% | +278.1% | +218.0% | -10.8% | +12.4% |
| 5Y Revenue / Share Growth | -94.0% | -91.4% | -37.3% | -70.8% | -52.4% | -86.7% | +1692.2% | +10975.6% | -- | -- |
| 10Y Revenue / Share Growth | -99.2% | +54.9% | +6840.3% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 63.3% | 64.0% | 64.8% | 66.8% | 67.6% | 69.0% | 70.8% | 71.9% |
| **Operating Margin** | -18.4% | -14.4% | -26.8% | -13.9% | -13.2% | -11.8% | -3.8% | -10.6% |
| **Net Profit Margin** | -34.3% | -24.8% | -60.2% | -39.0% | -20.5% | -20.4% | 2.5% | -8.5% |
| Return on Equity (ROE) | -63.7% | -40.4% | -96.9% | -172.1% | -56.4% | -71.5% | 4.7% | -17.0% |
| Return on Assets (ROA) | -20.3% | -13.6% | -30.5% | -20.0% | -10.5% | -10.9% | 1.3% | -4.5% |
| Current Ratio | 1.07x | 1.13x | 1.12x | 1.16x | 1.23x | 1.26x | 1.03x | -- |
| Quick Ratio | 0.96x | 1.00x | 1.00x | 1.03x | 1.08x | 1.07x | 0.87x | 0.72x |
| Debt to Equity | 0.37x | 0.34x | 0.36x | 0.92x | 0.58x | 0.73x | 0.36x | 0.43x |
| **Revenue Growth (YoY)** | +6.9% | +6.4% | -32.7% | -6.5% | -16.2% | +3.7% | +31.6% | -13.5% |
| Gross Profit Growth (YoY) | +2.7% | +1.5% | -40.7% | -10.8% | -23.4% | -7.2% | +23.6% | -26.1% |
| Operating Income Growth (YoY) | -- | -- | -267.9% | -- | -- | -- | -- | -153.9% |
| **Net Income Growth (YoY)** | -297.5% | -- | -240.7% | -1443.1% | +33.3% | -- | -- | -- |
| EPS Growth (YoY) | -195.2% | -- | -181.5% | -907.7% | -12.5% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | +57.2% | -- | +26.5% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | +57.7% | -- | +26.2% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
